Browsing by Subject "A61K 38/08"

Now showing items 1-8 of 8

    • Compositions and methods for drug-sensitization or inhibition of a cancer cell 
      Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Compositions and methods for drug-sensitization or inhibition of a cancer cell 
      Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Compositions and methods for drug-sensitization or inhibition of a cancer cell 
      Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Functional, cross-linked nanostructures for tandem optical imaging and therapy 
      Neumann, William L.; Dorshow, Richard B.; Freskos, John N.; Wooley, Karen L.; Lee, Nam S.; Lin, Yun; Sun, Guorong (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-05-30)
      The present invention provides optical agents comprising optically functional cross linked supramolecular structures and assemblies useful for tandem optical imaging and therapy. Supramolecular structures and assemblies ...
    • Functionalized protein-based materials and their uses 
      Bondos, Sarah; Bayless, Kayla; Matthews, Kathleen; Patterson, Jan; Abbey, Colette; Howell, David; Hsiao, Hao-Ching; Churion, Kelly; Tsai, Shang-Pu; Ramasamy, Sandhya; Porterpan, Dustin; Northern, Keira (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-03-16)
      Embodiments of the invention are directed to Ubx-fusion molecules that maintain their mechanical strength and properties even after being fused with Ubx. Ubx fusions with VEGF and other growth factors, cell signaling ...
    • Method of treating inflammatory bowel disease by administering a clip-inducing agent 
      Newell, Martha Karen; Harvey, Cassie L.; Tobin, Richard (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-12-09)
      The disclosure relates to methods for treating disorders of the mucosal tract such as the gastrointestinal system by targeting CLIP molecules. The methods are based on that CLIP in the groove of MHC class I or II molecules ...
    • Methods and products for treating preeclampsia and modulating blood pressure 
      Newell-rogers, Martha Karen; Mitchell, Brett; Newell, Evan (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-06-07)
      The invention relates to methods for altering biological parameters in a subject, such as reducing blood pressure in a subject, by displacing CLIP, using a CLIP inhibitor. The methods are useful for treating disorders such ...
    • Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N 
      Hruby, Victor J.; Cai, Minying; Morgan, Caurnel (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-05-19)
      Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising compound PG-20N in a ...